We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Analyzing immune responses to varied mRNA and protein vaccine sequences

    In response to the COVID-19 pandemic, different types of vaccines, such as inactive, live-attenuated, messenger RNA (mRNA), and protein subunit, have...

    Hyeong-Jun Park, Yoo-** Bang, ... Jae-Hwan Nam in npj Vaccines
    Article Open access 05 June 2023
  2. Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models

    Respiratory syncytial virus (RSV) is a leading cause of severe respiratory disease for which no licensed vaccine is available. We have previously...

    Eirikur Saeland, Leslie van der Fits, ... Roland C. Zahn in npj Vaccines
    Article Open access 23 March 2023
  3. Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production

    Severe acute respiratory syndrome coronavirus 2 had devastating consequences for human health. Despite the introduction of several vaccines, COVID-19...

    AytĂ¼l GĂ¼l, Sedef Erkunt Alak, ... Mert DĂ¶ÅŸkaya in Scientific Reports
    Article Open access 15 June 2024
  4. Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein

    The Paramyxoviridae family encompasses medically significant RNA viruses, including human respiroviruses 1 and 3 (RV1, RV3), and zoonotic pathogens...

    Johannes P. M. Langedijk, Freek Cox, ... Mark J. G. Bakkers in Nature Communications
    Article Open access 31 May 2024
  5. Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19

    During the COVID-19 pandemic, the development of prophylactic vaccines, including those based on new platforms, became highly relevant. One such...

    M. B. Borgoyakova, L. I. Karpenko, ... A. A. Ilyichev in Bulletin of Experimental Biology and Medicine
    Article 01 December 2022
  6. Prophylactic Hepatitis E Vaccine

    The hepatitis E has been increasingly recognized as an underestimated global disease burden in recent years. Subpopulations with more serious...
    Jun Zhang, Zizheng Zheng, Ningshao **a in Hepatitis E Virus
    Chapter 2023
  7. Long-term trial of protection provided by adenovirus-vectored vaccine expressing the PPRV H protein

    A recombinant, replication-defective, adenovirus-vectored vaccine expressing the H surface glycoprotein of peste des petits ruminants virus (PPRV)...

    Karin E. Darpel, Amanda Corla, ... Carrie Batten in npj Vaccines
    Article Open access 03 June 2024
  8. Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents

    Respiratory syncytial virus (RSV) is a leading cause of upper and lower respiratory tract infection, especially in children and the elderly. Various...

    Shingo Umemoto, Rika Nakahashi-Ouchida, ... Hiroshi Kiyono in npj Vaccines
    Article Open access 24 July 2023
  9. In-depth characterization of protein N-glycosylation for a COVID-19 variant-design vaccine spike protein

    COVID-19 is caused by SARS-CoV-2 infection and remains one of the biggest pandemics around the world since 2019. Vaccination has proved to be an...

    Jiangming Huang, Shouzeng Hou, ... Chenliang Zhou in Analytical and Bioanalytical Chemistry
    Article Open access 26 January 2023
  10. The CDE region of feline Calicivirus VP1 protein is a potential candidate subunit vaccine

    Background

    Feline calicivirus (FCV) infection causes severe upper respiratory disease in cats, but there are no effective vaccines available for...

    Lisha Li, Zirui Liu, ... Guiqing Peng in BMC Veterinary Research
    Article Open access 05 March 2024
  11. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine

    The 2002 SARS outbreak, the 2019 emergence of COVID-19, and the continuing evolution of immune-evading SARS-CoV-2 variants together highlight the...

    Peter J. Halfmann, Kathryn Loeffler, ... Ravi S. Kane in Nature Communications
    Article Open access 12 February 2024
  12. Plant Molecular Farming for Vaccine Development

    Vaccines are effective tools for the prophylaxis of infectious diseases. Various diseases have been eradicated using vaccines, and the importance of...
    Chapter 2024
  13. In Silico Structure-Based Vaccine Design

    Structure-based vaccine design (SBVD) is an important technique in computational vaccine design that uses structural information on a targeted...
    Sakshi Piplani, David Winkler, ... Nikolai Petrovsky in Computational Vaccine Design
    Protocol 2023
  14. Exosome-Based COVID-19 Vaccine

    Extracellular vesicles (EVs) enable cell-to-cell communication and, by delivering antigens, can stimulate the immune response strongly. Approved in...
    Jaeyoung Kim, Nikita Thapa in Cell-Secreted Vesicles
    Protocol 2023
  15. Computer-Aided Multi-Epitope Based Vaccine Design Against Monkeypox Virus Surface Protein A30L: An Immunoinformatics Approach

    Monkeypox, a viral zoonotic disease resembling smallpox, has emerged as a significant national epidemic primarily in Africa. Nevertheless, the recent...

    S. V. Ramprasadh, Santhosh Rajakumar, ... Rajan Chourasiya in The Protein Journal
    Article 24 August 2023
  16. Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2

    In response to COVID-19 pandemic, we have launched a vaccine development program against SARS-CoV-2. Here we report the safety, tolerability, and...

    Lorna Leal, Judit Pich, ... Elia Torroella in npj Vaccines
    Article Open access 29 September 2023
  17. Design of a novel multiepitope vaccine against Chlamydia pneumoniae using the extracellular protein as a target

    Chlamydia pneumoniae ( C. pneumoniae ) infection in humans is universal and causes various respiratory infectious diseases, making a safe and effective...

    **aomei Guo, **aohong Pan, ... Jiandong Shi in Scientific Reports
    Article Open access 12 September 2023
  18. Immunoinformatics design of novel multi-epitope vaccine against Trueperella Pyogenes using collagen adhesion protein, fimbriae, and pyolysin

    Trueperella pyogenes ( T. pyogenes ) is an opportunistic pathogen that causes infertility, mastitis, and metritis in animals. T. pyogenes is also a...

    Babak Beikzadeh in Archives of Microbiology
    Article 05 February 2024
  19. Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats

    ZF2001, a protein subunit vaccine against coronavirus disease 2019 (COVID-19), contains recombinant tandem repeat of dimeric receptor-binding domain...

    Yisheng Song, **** Shao, ... Lijiang Zhang in npj Vaccines
    Article Open access 24 May 2023
  20. Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

    The safety and immunogenicity of a protein-based tetravalent vaccine SCTV01E that contains spike protein ectodomain (S-ECD) of Alpha, Beta, Delta and...

    Suad Hannawi, Linda Saf Eldin, ... Liangzhi **e in Nature Communications
    Article Open access 08 July 2023
Did you find what you were looking for? Share feedback.